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Abstract 
Background: Melioidosis is endemic in tropical Australia and Southeast Asian countries and its causative organism 
Burkholderia pseudomallei is a recognized cause of pneumonia in these regions. Recent isolation of the organism in 
the soil of Kapasia, Gazipur, Bangladesh has proven its exposure among the population residing in endemic areas of 
our country. Pneumonia is the most common presentation of melioidosis. Acute, subacute and chronic pneumonia 
due to B. pseudomallei can present as primary or secondary pneumonia. Treatment of such cases are challenging as 
well. Till date, few cases of acute and chronic pneumonia due to melioidosis occurring in local Bangladeshis as well 
as in returning travelers to Europe have been reported. To the best of our knowledge, this is the first reported case of 
primary melioidosis pneumonia declared cured after a 27 weeks of treatment regimen from Bangladesh.
Case presentation: A 43-year-old Bangladeshi gentleman, known diabetic, hypertensive, smoker, presented with 
the complaints of recurrent episodes of low to high grade intermittent fever, productive cough with occasional 
haemoptysis and 10 kg weight loss over one and half months. Poorly responding to conventional antibiotics, he was 
suspected as a case of pulmonary tuberculosis. Examination and investigations revealed left sided consolidation 
with cavitary lesion, hepato-splenomegaly and sputum analysis confirmed growth of Burkholderia pseudomallei. The 
patient was successfully treated as a case of primary melioidosis pneumonia.
Conclusion: Often misdiagnosed and empirically treated as tuberculosis, untreated melioidosis pneumonia may 
even lead to death. Therefore, melioidosis should be suspected in appropriate clinical scenario in patients with a his-
tory of residing in or traveling to endemic areas. In Bangladesh, time has come to explore whether melioidosis should 
be considered as an emerging infectious disease.
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Background
Burkholderia pseudomallei, a gram-negative bacillus 
responsible for the infectious disease melioidosis, is a 
common soil and fresh water saprophyte in tropical and 
subtropical regions between latitudes 20°N and 20°S [1]. 
Although endemic in tropical Australia and in Southeast 
Asian countries where it is recognized as a public health 
problem [2], the increasing number of reported cases in 
Bangladesh [3] and India [1] are alarming. In Bangladesh, 
this organism has already been isolated from the soil of 
Kapasia,.Gazipur in 2013 [4], rendering this nation as a 
definite country for melioidosis. A recent study has also 
identified serological evidence to B. pseudomallei infec-
tion and its exposure being relatively common in local 
Bangladeshis [5]. Pneumonia in both acute and chronic 
forms are recognized as a mode of presentation of this 
disease and treatment of such cases are challenging. This 
case report highlights the successful treatment outcome 
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Case presentation
A 43-year-old Bangladeshi man, known hypertensive 
and a smoker (18 pack-year), was admitted under Inter-
nal Medicine Department of Bangladesh Institute of 
Research and Rehabilitation in Diabetes, Endocrine and 
Metabolic Disorders (BIRDEM) General Hospital, with 
the complaints of recurrent episodes of fever and cough 
for one and half months. Fever was intermittent, initially 
low grade, later became high grade (maximum recorded 
104  °F) which subsided with sweating, not associated 
with chills and rigor. His cough which was occasional and 
dry at first, later became more frequent, productive, and 
without chest pain, dyspnoea or leg swelling. Sputum was 
mucoid without any foul smell.
There were no history or features suggestive of chronic 
obstructive pulmonary disease, bronchial asthma and 
sinusitis. Previous tuberculosis or contact with known 
case was denied. He was a returning worker from Brunei, 
where he had been working as a carpenter since 2008. He 
had visited his home district Bhramanbaria, Bangladesh, 
four and half months prior to his illness.
During this period of illness he had lost 10 kg weight. He 
was treated in Brunei three times with oral antibiotics and 
antipyretics without much improvement. He was diagnosed 
as diabetes mellitus on his 3rd follow-up visit in Brunei and 
was treated with tablet glicazide. By that time he also devel-
oped occasional mild haemoptysis. Suspecting pulmonary 
tuberculosis, he was sent back to Bangladesh. On the day he 
returned from Brunei, he took admission in BIRDEM Gen-
eral Hospital for thorough.evaluation and management.
At the time of admission he had high grade fever, pro-
ductive cough (whitish sputum). On examination he 
looked ill, temperature was 102  °F, had oral candidiasis, 
was dehydrated without clubbing or lymphadenopathy. 
Features of consolidation in his left lung and palpable, 
non-tender hepato-splenomegaly (liver 2 cm, firm; spleen 
4 cm from respective costal margins) were present. Other 
systemic findings were unremarkable.
Reports of initial investigations done in Brunei were 
unavailable. During his stay at our hospital, investigations 
revealed a high erythrocyte sedimentation rate (ESR, 
150  mm in 1st hour) despite a normal complete blood 
count. His blood sugar profile (random blood sugar 
16.2  mmol/L, glycated hemoglobin 12.6  %) was uncon-
trolled. Chest x-ray posterior-anterior view showed 
homogenous opacity with a cavitary lesion occupying 
parts of left middle and lower zones (Figs.  1, 2). Ultra-
sonography of whole abdomen reported mildly enlarged 
liver with fatty change (Grade II) and enlarged spleen 
(16 cm) with left sided mild pleural effusion.
Sputum analysis revealed presence of plenty pus cells, 
gram negative bacteria on Gram’s stain and growth of B. 
pseudomallei (Fig. 3) which was sensitive to augmentin, 
aztroenam, cefixime, ceftriaxone, ceftazidime, cefo-
taxime, ciprofloxacin, co-trimoxazole, imipenem and 
piperacillin-tazobactum. Sputum polymerase chain reac-
tion (PCR) for B. pseudomallei was also positive. Sputum 
for malignant cell, acid fast bacilli (2 samples), GeneX-
pert Mycobacterium tuberculosis/rifampicin (MTB/RIF) 
were not detected and Montoux test was negative. Blood 
and urine cultures revealed no growth. Tripple antigen, 
liver function tests, serum creatinine, lipid profile were 
normal.
His high blood sugar level was controlled with subcu-
taneous premixed insulin. For melioidosis, he was treated 
Fig. 1 Chest x-ray posterior–anterior view on admission (04/09/2014) 
showing homogenous opacity with a cavitary lesion occupying parts 
of left middle and lower zones
Fig. 2 Plain x-ray of chest, left lateral view (on admission)
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with ceftazidime 2 g intravenous 8 h for 3 weeks followed 
by maitainance therapy with capsule doxycycline (100 mg 
twice daily) and tablet cotrimoxazole (160  +  800  mg, 
twice daily) for 6  months. He was also advised to quit 
smoking. He responded well to the treatment. His fever 
subsided after 13 days, cough became unproductive after 
20 days and subsided after 27 days.
On his first follow up visit at 2 weeks the patient was 
feeling better. Radiological improvement was evidenced 
by decreasing lung opacity on chest x-ray posterior-
anterior view (Fig. 4) and normal size of liver and spleen 
on ultrasonography of whole abdomen. Left sided 
pleural effusion was detected by both chest x-ray and 
ultrasonography.
Second follow up visit at 6 weeks demonstrated further 
symptomatic improvement including 2  kg weight gain. 
There was significant reduction of the lesion in his left lung 
radiologically (Fig. 5) and ESR was decreasing (54 mm in 
1st hour). Two days after this visit, the patient went back to 
Brunei to continue his job there and was advised for a fol-
low up visit on 6th April 2015 with reports.
At the time of his final follow up at 6 months, although 
the patient was unable to return home, the advised fol-
low-up investigations were done in Brunei and were sent 
by email. Reports revealed a normal complete blood 
count and ESR (2  mm in 1st hour). Chest x-ray poste-
rior–anterior view reported ‘no active lung lesion’. At 
this stage, treatment was stopped and the patient was 
declared cured of melioidosis after 27 weeks of treatment.
Discussion
Pneumonia is the most common presentation of meli-
oidosis occurring in approximately half of all cases. It 
is thought that lung involvement arises after hematog-
enous spread following inoculation [2]. Higher rainfall is 
significantly associated with sepsis and pneumonia sug-
gesting that environmental conditions during the mon-
soon season may be associated with inhalation rather 
than inoculation as the primary mode of acquisition [6]. 
B. pseudomallei strains differ in their individual ability to 
cause disease, the outcome also clearly depends on the 
immune status and response of the infected host [1].
Up to 80 % of patients with melioidosis have one or more 
risk factors for the disease, diabetes mellitus being the 
most important risk factor (up to 60 % of patients). Other 
risk factors include heavy alcohol use, chronic pulmonary 
disease, chronic renal disease, thalassamia, glucocorticoid 
therapy and cancer [7]. Cheng and Currie [2] in a review 
Fig. 3 Photograph showing growth of Burkholderia pseudomallei in 
Blood agar
Fig. 4 Chest x-ray posterior–anterior view after 2 weeks of treatment 
showing radiological improvement
Fig. 5 Second follow-up chest x-ray posterior–anterior view after 
6 weeks of treatment showing significant radiological improvement 
with decreased pleural effusion (left)
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stated that patients with diabetes mellitus have a high inci-
dence of melioidosis, with up to 60  % of patients having 
preexisting or newly diagnosed type 2 diabetes. Case–con-
trol and population-based studies in Australia and Thailand 
gave estimated relative risk of 5.9–13.1. [2] Our patient was 
diagnosed type 2 diabetic during his course of illness.
Melioidosis pneumonia is a diverse illness that can 
range from acute, fulminant sepsis with multifocal lung 
infiltrates to chronic infection that mimics tuberculosis 
both clinically and radiologically [8]. Melioidosis pneu-
monia can be the primary presenting feature, or can 
develop secondary to initial illness at a distant site, or 
can develop in patients with bacteremia without an initial 
evident focus [9]. B. pseudomallei may remain latent for 
many years and then reactivate; however, most melioido-
sis cases are thought to occur soon after exposure [10].
In a 21-year study in the top end of the Northern Ter-
ritory, Australia, cases of melioidosis pneumonia were 
observed. Acute/subacute melioidosis was diagnosed 
if symptoms had been present for <2  months; chronic 
melioidosis was diagnosed if symptoms at presentation 
had been present for ≥2  months. Primary pneumonia 
was diagnosed when there were clinical and radiologic 
features of pneumonia present within 48  h of admis-
sion and there was no other initial clinical focus evident. 
Secondary pneumonia was diagnosed when respiratory 
symptoms and pulmonary infiltrates developed 48  h 
after admission in patients with an initial non-pulmonary 
presentation. Among 624 cases of culture-confirmed 
melioidosis, primary pneumonia, accounted for 51  % of 
presentations, occurring mostly during the wet season. 
Nineteen percent cases developed secondary pneumonia 
during the course of their illness. The majority of primary 
pneumonia cases were acute/subacute (291 cases, 91 %); 
chronic disease (28 cases, 9 %) was seen less commonly. 
Acute/subacute infection was associated with bactere-
mia, septic shock, and death. While upper-lobe involve-
ment was common in both acute/subacute and chronic 
pneumonia, lower lobe or multilobar involvement was 
more common in acute/subacute pneumonia [11].
Haemoptysis is rare in acute disease but may be present 
in up to 31 % of patients with the chronic form of the dis-
ease. Pleural involvement occurs in 9–33 % of cases and 
thoracic empyema is occasionally seen. A more indolent 
presentation of melioidosis pneumonia is associated with 
a better outcome. The chest radiograph in acute disease 
commonly shows either a localized patch or bilateral 
diffuse patchy alveolar infiltration or multiple nodular 
lesions which may coalesce, cavitate (cavities are usually 
thin-walled and rarely contain air-fluid level) and form 
abscesses [12, 13].
In the chronic form of the disease, the chest radio-
graph findings may be difficult to distinguish from that 
of pulmonary tuberculosis which typically involves the 
upper lobes with patchy alveolar infiltrates and cavita-
tions. Sparing of the apical region and lack of calcifica-
tion suggest the likelihood of melioidosis rather than 
pulmonary tuberculosis [12, 13].
Our patient presented with features of primary pneu-
monia. He had significant weight loss, occasional haem-
optysis and was initially suspected as a case of pulmonary 
tuberculosis. Among the recognized risk factors [11] 
for primary melioidosis pneumonia he had a history of 
diabetes mellitus, smoking and his symptoms started 
during the wet season. Investigations confirmed melioi-
dosis pneumonia with multilobar lung involvement and 
cavitary lesions. Besides pneumonia, his hepato-sple-
nomegaly also resolved with treatment for melioidosis. 
Although he presented within 2 months of his symptoms, 
it was not possible to say whether it was acute or suba-
cute pneumonia due to lack of clear guidelines.
Till date, 6 cases of melioidosis pneumonia were 
reported in Bangladeshis among locals and as return-
ing travelers to Europe. Among them three were acute/
subacute cases [3, 14, 15] and three were chronic cases 
[16–18] One case was secondary melioidosis pneumo-
nia [15]. Five cases showed involvement of upper lung 
zone [3, 14, 16–18]. Cavity lesions were observed in three 
cases [3, 17, 18]. Mid and lower lung zone involvement 
was observed in our case, as was seen in another case 
with acute pneumonia [15]. Out of the six cases, four 
cases showed improvement with treatment but none of 
the cases were followed up till a complete cure [14, 15, 
17, 18] and two patients failed to respond to treatment 
and died [3, 16].
However, there remains a debate as from where our 
patient acquired the primary infection from, Bangladesh 
or Brunei? Prior to development of his symptoms, he had 
a history of recent traveling to his home district in Bang-
ladesh, where seropositivity to B. pseudomallei has been 
observed already [5]. On the other hand, Brunei is also 
well recognized as an endemic country for melioidosis 
[19, 20] where this patient has been working for the past 
few years.
To the best of our knowledge, this is the first case 
report of primary melioidosis pneumonia declared cured 
after a 27  weeks completed treatment regimen from 
Bangladesh.
Conclusion
Melioidosis, if diagnosed early and treated accordingly, 
can prevent complications, even save a patient’s life, as 
reported in this article. In countries where tuberculo-
sis is endemic, newly emerging diseases like melioidosis 
may be overlooked. Suspicion of melioidosis should be 
considered in appropriate clinical scenario, especially 
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in patients with a history of residing in or traveling to 
endemic areas. In Bangladesh, isolation of B. pseudomal-
lei from the soil, serological evidence of exposure to the 
organism and increasing numbers of diagnosed meli-
oidosis cases among Bangladeshis are alarming. This 
warrants in creating an awareness among clinicians and 
microbiologists in Bangladesh about this organism and 
the disease caused by it.
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